DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, D. R.
Right arrow Articles by Thompson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, D. R.
Right arrow Articles by Thompson, J. A.

A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice

DR Petersen, KJ Norris and JA Thompson

The disposition of nicotine, cotinine, and nicotine N-oxide was investigated in male C57BL, DBA, and C3H mice following an ip injection of nicotine (1.0 mg/ml). The half-lives (t1/2) of nicotine in blood were 5.9 to 6.9 min. The rapid elimination of nicotine was accompanied by a rapid accumulation of metabolites; maximal concentrations of cotinine in blood (204 to 364 ng/ml) were achieved in 10 min and nicotine N-oxide (23 ng/ml in C3H mice) in 15 min. The t1/2 in blood was 20.1 to 39.8 min for cotinine and 18.4 min for nicotine N-oxide. The t1/2 values for nicotine in brain were similar to those in blood, but the values for liver were slightly larger (6.3 to 9.2 min) and interstrain differences were significant. A large strain-related difference in the t1/2 for cotinine was found; the metabolite was eliminated from the blood of DBA mice at only about one-half the rate determined for the other strains. The t1/2 for nicotine N-oxide in liver ranged from 12.7 to 27.3 min; the values were significantly different with C57BL greater than DBA greater than C3H. Strain-related differences were also observed in response to chronic exposure to cigarette smoke. The t1/2 of injected nicotine appeared to be slightly decreased in C57BL and DBA mice but was increased by 60% in livers of C3H mice compared to a control group.

Volume 12, Issue 6, pp. 725-731, 11/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Chem SensesHome page
A. R. Glatt, K. Denton, and J. D. Boughter Jr
Variation in Nicotine Consumption in Inbred Mice Is Not Linked to Orosensory Ability
Chem Senses, January 1, 2009; 34(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Eugenin, M. Otarola, E. Bravo, C. Coddou, V. Cerpa, M. Reyes-Parada, I. Llona, and R. von Bernhardi
Prenatal to Early Postnatal Nicotine Exposure Impairs Central Chemoreception and Modifies Breathing Pattern in Mouse Neonates: A Probable Link to Sudden Infant Death Syndrome
J. Neurosci., December 17, 2008; 28(51): 13907 - 13917.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. I. Damaj, C. Fonck, M. J. Marks, P. Deshpande, C. Labarca, H. A. Lester, A. C. Collins, and B. R. Martin
Genetic Approaches Identify Differential Roles for {alpha}4beta2* Nicotinic Receptors in Acute Models of Antinociception in Mice
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. I. Damaj, E. C. K. Siu, E. M. Sellers, R. F. Tyndale, and B. R. Martin
Inhibition of Nicotine Metabolism by Methoxysalen: Pharmacokinetic and Pharmacological Studies in Mice
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 250 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Fonck, B. N. Cohen, R. Nashmi, P. Whiteaker, D. A. Wagenaar, N. Rodrigues-Pinguet, P. Deshpande, S. McKinney, S. Kwoh, J. Munoz, et al.
Novel Seizure Phenotype and Sleep Disruptions in Knock-In Mice with Hypersensitive {alpha}4* Nicotinic Receptors
J. Neurosci., December 7, 2005; 25(49): 11396 - 11411.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Davis, J. R. James, S. J. Siegel, and T. J. Gould
Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice
J. Neurosci., September 21, 2005; 25(38): 8708 - 8713.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
O. A. Ghosheh, L. P. Dwoskin, D. K. Miller, and P. A. Crooks
Accumulation of Nicotine and Its Metabolites in Rat Brain After Intermittent or Continuous Peripheral Administration of [2'-14C]Nicotine
Drug Metab. Dispos., April 13, 2001; 29(5): 645 - 651.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. P. Dwoskin, L. Teng, S. T. Buxton, and P. A. Crooks
(S)-(-)-Cotinine, the Major Brain Metabolite of Nicotine, Stimulates Nicotinic Receptors to Evoke [3H]Dopamine Release from Rat Striatal Slices in a Calcium-Dependent Manner
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 905 - 911.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. R. Grady, E. U. Grun, M. J. Marks, and A. C. Collins
Pharmacological Comparison of Transient and Persistent [3H]Dopamine Release from Mouse Striatal Synaptosomes and Response to Chronic L-Nicotine Treatment
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 32 - 43.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
P. A. Crooks, M. Li, and L. P. Dwoskin
Metabolites of Nicotine in Rat Brain After Peripheral Nicotine Administration. Cotinine, Nornicotine, and Norcotinine
Drug Metab. Dispos., January 1, 1997; 25(1): 47 - 54.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics.